Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells.

Rudqvist NP, Pilones KA, Lhuillier C, Wennerberg E, Sidhom JW, Emerson RO, Robins HS, Schneck J, Formenti SC, Demaria S.

Cancer Immunol Res. 2018 Feb;6(2):139-150. doi: 10.1158/2326-6066.CIR-17-0134. Epub 2017 Nov 27.

PMID:
29180535
2.

Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma.

Kremer V, Ligtenberg MA, Zendehdel R, Seitz C, Duivenvoorden A, Wennerberg E, Colón E, Scherman-Plogell AH, Lundqvist A.

J Immunother Cancer. 2017 Nov 6;5(1):88. doi: 10.1186/s40425-017-0292-8. No abstract available.

3.

Immune recognition of irradiated cancer cells.

Wennerberg E, Vanpouille-Box C, Bornstein S, Yamazaki T, Demaria S, Galluzzi L.

Immunol Rev. 2017 Nov;280(1):220-230. doi: 10.1111/imr.12568. Review. Erratum in: Immunol Rev. 2018 Mar;282(1):276.

PMID:
29027232
4.

Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma.

Kremer V, Ligtenberg MA, Zendehdel R, Seitz C, Duivenvoorden A, Wennerberg E, Colón E, Scherman-Plogell AH, Lundqvist A.

J Immunother Cancer. 2017 Sep 19;5(1):73. doi: 10.1186/s40425-017-0275-9. Erratum in: J Immunother Cancer. 2017 Nov 6;5(1):88.

5.

Barriers to Radiation-Induced In Situ Tumor Vaccination.

Wennerberg E, Lhuillier C, Vanpouille-Box C, Pilones KA, García-Martínez E, Rudqvist NP, Formenti SC, Demaria S.

Front Immunol. 2017 Mar 13;8:229. doi: 10.3389/fimmu.2017.00229. eCollection 2017. Review.

6.

IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.

Mao Y, van Hoef V, Zhang X, Wennerberg E, Lorent J, Witt K, Masvidal L, Liang S, Murray S, Larsson O, Kiessling R, Lundqvist A.

Blood. 2016 Sep 15;128(11):1475-89. doi: 10.1182/blood-2016-02-698027. Epub 2016 Jul 27.

7.

Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression.

Koelwyn GJ, Wennerberg E, Demaria S, Jones LW.

Oncology (Williston Park). 2015 Dec;29(12):908-20, 922. Review.

8.

In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment.

Vanpouille-Box C, Pilones KA, Wennerberg E, Formenti SC, Demaria S.

Vaccine. 2015 Dec 16;33(51):7415-7422. doi: 10.1016/j.vaccine.2015.05.105. Epub 2015 Jul 3. Review.

9.

CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo.

Wennerberg E, Kremer V, Childs R, Lundqvist A.

Cancer Immunol Immunother. 2015 Feb;64(2):225-35. doi: 10.1007/s00262-014-1629-5. Epub 2014 Oct 26.

PMID:
25344904
10.

Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.

Wennerberg E, Pfefferle A, Ekblad L, Yoshimoto Y, Kremer V, Kaminskyy VO, Juhlin CC, Höög A, Bodin I, Svjatoha V, Larsson C, Zedenius J, Wennerberg J, Lundqvist A.

Clin Cancer Res. 2014 Nov 15;20(22):5733-44. doi: 10.1158/1078-0432.CCR-14-0291. Epub 2014 Sep 11.

11.

Dysregulated Fc receptor function in active rheumatoid arthritis.

Magnusson SE, Wennerberg E, Matt P, Lindqvist U, Kleinau S.

Immunol Lett. 2014 Nov;162(1 Pt A):200-6. doi: 10.1016/j.imlet.2014.08.016. Epub 2014 Sep 4.

PMID:
25194756
12.

Gap junction intercellular communications regulate NK cell activation and modulate NK cytotoxic capacity.

Tittarelli A, Mendoza-Naranjo A, Farías M, Guerrero I, Ihara F, Wennerberg E, Riquelme S, Gleisner A, Kalergis A, Lundqvist A, López MN, Chambers BJ, Salazar-Onfray F.

J Immunol. 2014 Feb 1;192(3):1313-9. doi: 10.4049/jimmunol.1301297. Epub 2013 Dec 27.

13.

A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells.

Sarhan D, Wennerberg E, D'Arcy P, Gurajada D, Linder S, Lundqvist A.

Cancer Immunol Immunother. 2013 Aug;62(8):1359-68. doi: 10.1007/s00262-013-1439-1. Epub 2013 May 21.

PMID:
23689729
14.

Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms.

Mao Y, Poschke I, Wennerberg E, Pico de Coaña Y, Egyhazi Brage S, Schultz I, Hansson J, Masucci G, Lundqvist A, Kiessling R.

Cancer Res. 2013 Jul 1;73(13):3877-87. doi: 10.1158/0008-5472.CAN-12-4115. Epub 2013 Apr 30.

15.

Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling.

Wennerberg E, Sarhan D, Carlsten M, Kaminskyy VO, D'Arcy P, Zhivotovsky B, Childs R, Lundqvist A.

Int J Cancer. 2013 Oct 1;133(7):1643-52. doi: 10.1002/ijc.28163. Epub 2013 Apr 11.

16.

Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells.

Kiessling R, Okita R, Mougiakakos D, Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kono K.

Oncoimmunology. 2012 Oct 1;1(7):1200-1201.

17.

Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ.

Sarhan D, D'Arcy P, Wennerberg E, Lidén M, Hu J, Winqvist O, Rolny C, Lundqvist A.

Eur J Immunol. 2013 Jan;43(1):249-57. doi: 10.1002/eji.201242735. Epub 2012 Oct 26.

18.

HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.

Okita R, Mougiakakos D, Ando T, Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kiessling R.

J Immunol. 2012 Mar 1;188(5):2136-45. doi: 10.4049/jimmunol.1102237. Epub 2012 Feb 1.

Supplemental Content

Loading ...
Support Center